Skip to main content
Promising results for drug combo against cystic fibrosis

A late-stage trial in The New England Journal of Medicine found that tezacaftor combined with ivacaftor was safe and effective compared with placebo in patients with cystic fibrosis who were homozygous for the Phe508del mutation.

Full Story: